Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.02
- Piotroski Score 3.00
- Grade Buy
- Symbol (EVO)
- Company Evotec SE
- Price $5.36
- Changes Percentage (1.04%)
- Change $0.06
- Day Low $5.17
- Day High $5.37
- Year High $12.00
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
- Last Earnings N/A
- Ex-Dividend for 5/16 Dividend 01/11/2019
- Dividend Payable N/A
- Today N/A
- Next Earnings (Estimated) 03/27/2025
- Fiscal Year End N/A
- Average Stock Price Target $8.00
- High Stock Price Target $8.00
- Low Stock Price Target $8.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.28
- Trailing P/E Ratio -17.07
- Forward P/E Ratio -17.07
- P/E Growth -17.07
- Net Income $-83,913,000
Income Statement
Quarterly
Annual
Latest News of EVO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Starmer and the farmer's revolt - Politics Weekly UK
Farmers protested in Westminster against inheritance tax changes in last month's budget. The government insists it will only impact a few farms, but many fear it could lead to the downfall of their bu...
By The Guardian | 1 day ago -
TV Time points to Apple's 'significant power' over devolpers after being removed from App Store
TV Time, a beloved TV and movie tracking app with 30+ million users, was unexpectedly removed from the Apple App Store due to an IP complaint. After resolving the issue, the app is back on the store, ...
By TechCrunch | 1 day ago -
Rafael Nadal's tennis evolution into an all-time great: 'Every year he improved a little'
Rafael Nadal's illustrious tennis career was marked by evolution, resilience, and relentless pursuit of improvement. From his early days as a clay-court specialist to becoming a versatile champion, Na...
By The New York Times | 2 days ago
